PMM2 and pneumonia: Given that both patients 1 and 2 developed AKI while receiving treatment for gastroenteritis and pneumonia, respectively, we hypothesize that compromised immune function characteristic of PMM2‐CDG may have played a role in exacerbating the progression of kidney disease.